FIELD: biotechnology.
SUBSTANCE: recombinant strain of E. coli Origami 2 (DE3) pET28ahGFAP is proposed for the production of recombinant human glial fibrillary acidic protein (GFAP) for the use in diagnostic purposes, obtained by transforming the strain E. coli Origami 2 (DE3) with the plasmid pET28a-hGFAP, shown in Fig. 2. A method of producing recombinant human glial fibrillary acidic protein using the specified strain is also proposed.
EFFECT: invention provides the possibility of obtaining recombinant human glial fibrillary acidic protein.
2 cl, 4 dwg, 2 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING SEVERITY OF ANTI-NMDA-RECEPTOR ENCEPHALITIS WITH MANIFESTED PSYCHOPATHOLOGICAL SYMPTOMS | 2024 |
|
RU2840435C1 |
| DIAGNOSTIC TECHNIQUE FOR TELENCEPHALIC GLYOSIS IN CHILDREN WITH CONGENITAL INFECTIONS | 2012 |
|
RU2488831C1 |
| PLASMID, METHOD FOR RECOMBINANT EXPRESSION OF ANTIMICROBIAL PEPTIDE, RECOMBINANT ANTIMICROBIAL PEPTIDE | 2024 |
|
RU2831834C1 |
| ESCHERICHIA COLI POLY(A)-POLYMERASE ENZYME PRODUCER STRAIN | 2022 |
|
RU2825470C2 |
| METHOD FOR STIMULATING SPINAL CORD REGENERATION WITH GENETICALLY MODIFIED HUMAN UMBILICAL CORD BLOOD CELLS | 2013 |
|
RU2521225C2 |
| STRAIN-PRODUCER OF METHIONINE-FREE CRM197 BASED ON CELLS E. coli BL21 (DE3) | 2015 |
|
RU2575621C1 |
| METHOD OF PRODUCING RECOMBINANT ANTIMICROBIAL PEPTIDE UBI18-35, RECOMBINANT PLASMID DNA pET31b-2xUBI18-35 AND PRODUCER-PRODUCER OF ESCHERICHIA COLI BL21 ROSETTA DE3 pLusS/pET31b-2HUBI18-35 ANTIMICROBIAL PEPTIDE UBI18-35 | 2018 |
|
RU2698037C1 |
| METHOD OF PRODUCING RECOMBINANT PROTEIN OMP25d-OMP19-OMP10his | 2024 |
|
RU2825400C1 |
| METHOD OF PRODUCING A RECOMBINANT NUCLEASE CAS ESSENTIALLY FREE OF BACTERIAL ENDOTOXINS, THE PREPARATION OBTAINED BY THIS METHOD AND CONTAINING A KIT FOR USE IN A CRISPR/Cas SYSTEM | 2019 |
|
RU2707542C1 |
| STRAIN E coli BL21(DE3)/pET-hHSP70 - PRODUCENT OF PROTEIN OF HEAT SHOCK IN HUMANS HSP70 | 2006 |
|
RU2333956C1 |
